Melatonin Gummies Are a Prescription Drug in the UK, a Sweet in Florida and in 117,093 Children’s Prescriptions – Here’s What 25 Lab-Tested Bottles Actually Contained in 2026
There’s a bottle of melatonin gummies in a surprising number of British bathroom cabinets right now, and almost all of them arrived the same way: in a suitcase, from a Walgreens or a CVS, bought for about eight dollars next to the sun cream. Strawberry flavour. Cartoon moon on the label. Perfectly legal to buy in Orlando, perfectly illegal to sell in Orpington.
In This Article
- Why melatonin gummies are a medicine in Britain and a sweet in Florida
- What 25 lab-tested bottles actually contained
- 117,093 children and the prescription boom nobody planned
- Seven minutes: what it does for an adult who can't drop off
- The one job it does properly: jet lag
- The magnesium gummy that turned out to be melatonin
- Where this leaves you this autumn
Melatonin gummies sit in an odd legal gap in the UK. The hormone inside them is a prescription-only medicine here – the same regulatory category as antibiotics and blood pressure tablets – yet it’s sold as a sweet in the United States and as a food supplement across much of Europe. And because it’s so easy to get hold of abroad, plenty of people assume the British rule is a quirk rather than a judgement about evidence. Having spent a fortnight reading the trials, the prescribing data and one alarming lab report, I think it’s a bit of both.
Here’s what the gummies actually do, who’s really taking them in Britain, and why the ones in your cabinet may contain nothing like the dose on the label.
Why melatonin gummies are a medicine in Britain and a sweet in Florida
Melatonin is a hormone your pineal gland makes in the evening as light fades. Synthetic melatonin is chemically identical, which is why the Americans treat it as a dietary supplement: it’s “natural”, so it goes on the shelf next to vitamin C. The Food and Drug Administration doesn’t check the dose before sale and doesn’t have to.
The UK took the opposite view years ago. The Medicines and Healthcare products Regulatory Agency classifies melatonin as a Prescription Only Medicine in every form – tablet, liquid, spray, gummy – on the basis that it’s a hormone with real effects on the body, that the right dose and timing matter, and that nobody should be self-prescribing it indefinitely. You can’t buy it in Boots. Holland & Barrett doesn’t stock it. The “melatonin” you see on a UK shelf is almost always something else with a sleepy-sounding name: valerian, 5-HTP, or a magnesium blend marketed at bedtime.
Bringing a bottle back for your own use isn’t a criminal matter. Selling it is. That’s why the UK listings you find online are either grey imports from sellers who’ll vanish next month, or products that skip the word “melatonin” entirely and hope you’ll read between the lines.
Is the British position paranoid? Not really. Melatonin has a short list of known side effects – headache, daytime drowsiness, vivid dreams, a bit of nausea – and no known withdrawal syndrome. But the prescription rule does something else that’s easy to miss. It means the melatonin you get in this country has been through a licensed factory and contains what the box says. That turns out to matter more than most people realise.
What 25 lab-tested bottles actually contained
In 2023 a team led by Pieter Cohen at Harvard Medical School bought 25 melatonin gummy products from American shops and sent them to a lab. The results, published in JAMA, are the single most useful thing to know before you eat one.
Twenty-two of the 25 were mislabelled. The actual melatonin content ranged from 74% of the stated dose to 347% of it. Only three products – three – were within 10% of what the label claimed. One product that advertised melatonin contained none at all; it was cannabidiol. Among the rest, the real dose per serving ran from 1.3mg to 13.1mg.
Sit with that 347% figure for a second. A “5mg” gummy could be delivering over 17mg. The NHS maximum for an adult with a long-term sleep condition, prescribed by a specialist, is 10mg. And these were mainstream brands from mainstream shops, not something off a market stall.
Gummies are the worst format for this, and the reason is mundane. Melatonin degrades over time, so manufacturers overfill to make sure the product still meets its label at the end of its shelf life. In a pressed tablet you can control that fairly precisely. In a gelatin gummy – cooked in a vat, poured into moulds, cooled – the active ingredient doesn’t distribute evenly, and the overfill gets generous. There’s no regulator sampling batches to catch it.
So the honest answer to “how much melatonin am I taking?” for anyone using an American gummy is: you don’t know, and the manufacturer may not either.
117,093 children and the prescription boom nobody planned
The other half of the melatonin story in Britain is happening entirely within the law, and it’s much bigger than the suitcase trade.
Data obtained by The Pharmaceutical Journal under Freedom of Information rules found that 117,093 patients aged 17 or under were prescribed melatonin in England in a single quarter of 2024/25. Nine years earlier the figure for the same quarter was 33,926. That’s a 245% rise, and it has kept climbing since the Journal first flagged it as “shocking” back in 2022.
Almost all of these children have ADHD or are autistic. Both conditions come with sleep problems that can be brutal for the whole household, and melatonin is now licensed in the UK for children aged six to 17 with ADHD where sleep hygiene hasn’t worked. Prescribers like it because the alternatives are worse: zopiclone prescriptions in children have fallen from 631 to 146 over the same period, diazepam from 2,833 to 1,627. Nobody sensible wants a nine-year-old on a Z-drug.
But the same reporting quotes Beryl Navti, a consultant pharmacist in child mental health services in north east London, describing melatonin as having become a “pacifier” – used even where the benefits are limited, because the waiting list for psychological help is so long. A 2022 audit by the Prescribing Observatory for Mental Health found just under a third of children starting melatonin hadn’t tried any non-drug approach first. NICE says it should be started by a specialist and reviewed every six months. In practice, follow-up is patchy.
None of this is an argument against melatonin for the child who needs it. It’s an argument that the drug is being asked to fill a gap that isn’t pharmacological. And it’s the reason the MHRA cares so much about what’s in an unregulated gummy: a large chunk of the people eating them are children.
Seven minutes: what it does for an adult who can’t drop off
For the ordinary adult – tired, wired, scrolling at 1am – the evidence for melatonin is real but small, and the number you need is seven.
The most-cited meta-analysis, Ferracioli-Oda and colleagues in PLOS One, pooled 19 randomised trials with 1,683 participants who had a primary sleep disorder. On melatonin, people fell asleep 7.06 minutes faster than on placebo, and slept 8.25 minutes longer in total. The authors called the effect “modest”. Sleep quality scores improved a little too. The effect didn’t fade with continued use, and higher doses and longer trials did somewhat better, which is more than can be said for most bedtime supplements.
Seven minutes is not nothing. If you habitually lie awake for 40 minutes, knocking that down to 33 is a difference you’d notice over a fortnight. But it’s a long way from the “out like a light” promise of the packaging, and it’s far less than what a proper course of cognitive behavioural therapy for insomnia delivers, which is the thing NICE actually recommends first and which a growing number of NHS areas in England now offer free through the Sleepio app.
There’s a second thing the trials keep showing that the gummy market ignores: dose. The licensed UK product for adults over 55, Circadin, is a 2mg slow-release tablet. The trials that work generally use 0.5mg to 5mg. The American gummies routinely say 10mg on the front, and as we’ve seen, might contain 20. More melatonin doesn’t mean more sleep; the receptors saturate. It mostly means a heavier head the next morning.
Compared with what else is on the shelf, though, melatonin is one of the few bedtime products with any trial evidence at all. We looked at magnesium for sleep in July and found the whole case rested on trials of 151 people. Mouth taping has ten studies, all rated poor quality. Melatonin has 19 randomised trials and a measurable, if small, effect. That’s a low bar, but it clears it.
The one job it does properly: jet lag
Where melatonin stops being a marginal sleep aid and becomes a properly useful drug is jet lag, and this is also where the UK rules quietly relax.
The mechanism is different. For insomnia you’re asking melatonin to knock you out, which it does only weakly. For jet lag you’re asking it to tell your body clock what time it is, which is what the hormone is for. The Cochrane review on the subject found melatonin reduced jet lag in nine out of ten trials for people crossing five or more time zones, with the benefit greatest flying east. Take it at local bedtime on arrival and the clock resets faster.
The NHS now lists a jet lag dose openly: one 3mg standard tablet at bedtime for up to five days, with a maximum of 16 courses a year. It’s still prescription-only, but it’s a prescription a private online pharmacy will issue after a short questionnaire, typically for somewhere between £10 and £30 depending on the pharmacy and the quantity. That’s a legitimate, dose-controlled route that didn’t really exist five years ago, and for anyone flying to the US or the Far East for the October half term it’s a better bet than a gummy of unknown strength.
One caveat that gets lost. The clocks going back on 25 October is a one-hour shift. That’s not jet lag and melatonin won’t help. Your body will sort a single hour out in a day or two on its own; a bright light in the morning does more for the autumn slump than anything you swallow at night.
The magnesium gummy that turned out to be melatonin
If you want a single story that explains why the MHRA bothers, it happened last August.
A children’s supplement called Nutrition Ignition Kids Magnesium Glycinate Gummies was being sold online in the UK as a food supplement for children aged four and up, marketed for “calm, focus and digestion”. The MHRA tested two batches. Each gummy contained between 1.5mg and 1.7mg of melatonin – a prescription-only medicine – and the word melatonin appeared nowhere on the packaging. The dosing advice was one or two gummies a day. The starting dose for a child on prescription is 1mg.
The regulator’s chief safety officer, Dr Alison Cave, told parents to stop using it and bin it, and the product was pulled from sale. No serious harm was reported. But think about what it means: a parent who’d deliberately avoided melatonin, perhaps on their GP’s advice, was giving it to a four-year-old twice a day without knowing.
Was it deliberate? The MHRA didn’t say. But it fits a pattern. A UK seller can’t legally put melatonin on the label, so the commercial temptation is to put it in the product and label something else – and a gummy that actually makes children sleepy gets very good reviews. That’s the grey market the prescription rule is trying to hold back, and it’s a stronger argument for the rule than anything in the pharmacology.
Where this leaves you this autumn
My own view, for what it’s worth: the melatonin gummy is overrated as a sleep aid and underrated as a jet lag drug, and the format itself is the problem. If you want melatonin, you want a tablet with a known dose from a regulated source, and in Britain that means a prescription. The US gummies aren’t dangerous in the way that word usually implies. They’re just a dice roll on dose, dressed up as a sweet, and for a child that’s a poor combination.
If your sleep problem is falling asleep, and it’s been going on for weeks rather than days, the thing with the strongest evidence is CBT for insomnia, and Sleepio is free on the NHS in a growing list of areas – ask your GP, or check the app’s postcode lookup. It’s a bit of a faff for the first fortnight. It also works better than any pill on this page.
If you’re over 55 with short-term insomnia, a GP can prescribe Circadin for up to 13 weeks, and it’s worth asking rather than importing. If you’re flying long-haul, a private pharmacy prescription for 3mg tablets is cheap and legal. And if you’ve got a bottle of American gummies in the cabinet, keep them well away from children, don’t stack them with anything else that makes you drowsy, and don’t assume “5mg” means 5mg.
What I’d stop doing entirely is buying “sleep gummies” from UK websites that won’t say what’s in them. After last August, the only sensible assumption is that the ones that work are working for a reason the label doesn’t mention.
So what’s actually in your bathroom cabinet – and do you know how much of it you’re taking?
